Therapy Areas: Diabetes
Abbott completes Bigfoot Biomedical acquisition
25 September 2023 - Abbott (NYSE: ABT), a US-based global healthcare company, announced on Friday that it has completed the acquisition of Bigfoot Biomedical, a California-based company that develops ...
MicuRx Pharmaceuticals' Contezolid and Contezolid acefosamil receive Fast Track Designation and US FDA QIDP
25 September 2023 - MicuRx Pharmaceuticals, Inc., a US-based biopharmaceutical company, announced on Friday that it has received Qualified Infectious Disease Product (QIDP) and Fast Track Designation ...
Nevro highlights cost savings with 10 kHz spinal cord stimulation therapy
18 September 2023 - Medical device company Nevro Corp. (NYSE: NVRO), that specialises in chronic pain treatment, on Monday released new data showcasing the cost-effectiveness of its proprietary 10 kHz...
Evoke Pharma receives USPTO Notice of Allowance for GIMOTI patent
14 September 2023 - Pharmaceutical company Evoke Pharma Inc (NASDAQ:EVOK) announced on Thursday that it has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for its paten...
DexCom expands real-time CGM access for half a million diabetes patients in France
12 September 2023 - DexCom Inc (Nasdaq: DXCM), a provider of real-time continuous glucose monitoring for people with diabetes, on Tuesday announced the availability of its Dexcom ONE real-time continu...
Abbott signs definitive agreement to acquire Bigfoot
6 September 2023 - Abbott (NYSE: ABT), a Chicago-based global healthcare company, announced on Tuesday that it has signed a definitive agreement to acquire Bigfoot Biomedical, a California-based compa...